CAT: Phystrac bij CTS Julie Staals Sept 2007
P : CTS I : tractie (Phystrac) C : geen / andere interventie O : klachtenverlichting
Cochrane CBO-richtlijn Non-surgical treatment (other than steroid injection) for cts 2003 Geen tractie-therapie vermeld CBO-richtlijn Diagnostiek en behandeling van cts 2005
Pubmed (carpal tunnel syndrome AND traction) New carpal ligament traction device for the treatment of cts unresponsive to conservative therapy. Porrata H, Porrata A, Sosner J. J Hand Ther. 2007;20(1):20-7. C-trac, niet beschikbaar Intermittend axial wrist traction as conservative treatment for cts: a case series. Brunarski D, Kleinberg B, Wilkins K. J Can Chiropr Assoc. 2004;48(3):211-216. 4 patiënten
pilot study Phystrac (1) Inclusie: www.cont-ex.nl pilot study Phystrac (1) Inclusie: Klachten passend bij CTS Fysiotherapeut bevestigt diagnose
pilot study Phystrac (2) 12 patienten geincludeerd 12 behandelingen (12 weken) Evaluatie voor behandeling, na 2 en 3 mnd Inclusie, behandeling en evaluatie door fysiotherapeut Uitval n=3 (analyse n=9)
pilot study Phystrac (3) Controle groep: proefschrift Gerritsen (2002) Polsspalk N=? The success rate was calculated with the general improvement score. In the traction group 4 out of 6 patients judged their condition as completely recovered or much improved after 12 weeks of treatment, resulting in a success rate of 66%. In the splinting group 46 out of 86 patients judged their condition as completely recovered or much improvement after 3 months of treatment, resulting in a success rate of 54%. No significant differences were found between de success rates of the traction group and the splinting group.
Conclusie Beter onderzoek nodig met (onder andere) meer patienten controlegroep, en langere follow-up duur